Navigation Links
Renal Physicians Association 2009 Annual Meeting
Date:1/7/2009

ng offers, this unique venue allows nephrologists an opportunity to network with their colleagues from around the country and obtain practical advice on issues we grapple with every day. Register today for the 2009 RPA Annual Meeting March 20-23 in Baltimore, Maryland at http://www.renalmd.org/meeting/registration.cfm. Register before January 15th and save $100 off the registration fee.

The Renal Physicians Association (RPA) is the professional organization of nephrologists whose goal is to ensure quality care under the highest standards of medical practice for patients with kidney disease and related disorders. For more information about RPA or the 2009 Annual Meeting, contact Desiree Bryant, Director of Meetings at 301-468-3518 or dbryant@renalmd.org.


'/>"/>
SOURCE Renal Physicians Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Renal function and heart disease, and more
2. Incidental findings found when radiologists take a broader look at renal MRA
3. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
4. Nephrologists summarize new renal research during public policy news briefing at Renal Week
5. PLC Medical Systems to Display RenalGuard(TM) During Renal Week 2007
6. FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
7. Serum carcinoembryonic antigen level can reflect adrenal adenoma
8. Renal Solutions, Inc. Announces Acquisition by Fresenius Medical Care
9. Follow-up imaging of benign-appearing incidental adrenal masses is unnecessary
10. UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy
11. PLC Systems Receives CE Mark Approval for RenalGuard(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Harm Reduction for Alcohol 3A An Idea Whose Time Has Arrived 62050 1Harm Reduction for Alcohol 3A An Idea Whose Time Has Arrived 62050 2The Doctor Will See You Now Online 62045 1The Doctor Will See You Now Online 62045 2Blue Marble Energy OPDA Awarded 242M by WAs Community Economic Revitalization Board 14961 1Blue Marble Energy OPDA Awarded 242M by WAs Community Economic Revitalization Board 14961 2